Back to Blog

Why Graph Reasoning Beats LLM-Only Approaches in Biomedical AI

March 28, 2026 · 7 min read

Large language models have transformed how we interact with medical information. Tools like ChatGPT can explain drug mechanisms in fluent, accessible language. But when the stakes are clinical decision-making, pharmacovigilance, or regulatory safety, fluency is not enough. What matters is whether every claim can be traced to a verifiable source.

The Hallucination Problem

LLMs are probabilistic text generators. They predict the next token based on patterns learned from training data. When asked "Why does lisinopril cause cough?", an LLM might produce a perfectly reasonable answer that mentions ACE inhibition and bradykinin accumulation. But it might also confidently cite a study that does not exist, invent a protein interaction that has never been observed, or conflate two different pharmacological mechanisms.

In medicine, a hallucinated reference is not a minor inconvenience — it is a safety risk. If a clinical decision support system surfaces a fabricated mechanism, it could lead to incorrect treatment decisions.

What Graph Reasoning Does Differently

Graph-based reasoning starts from structured, curated data. Instead of generating text and hoping it matches reality, the system queries databases like ChEMBL (for drug-target interactions), Reactome (for biological pathways), CTD (for chemical-gene-disease relationships), and OpenFDA FAERS (for adverse event reports).

These data points are assembled into a knowledge graph where nodes represent biomedical entities (drugs, proteins, pathways, diseases) and edges represent relationships that have been experimentally observed, curated by domain experts, or reported in the literature.

The system then traverses this graph to find causal chains — paths that connect a drug to an effect through intermediate targets and pathways. Each edge in the chain carries metadata: the source database, the evidence type, a confidence score, and often a PubMed ID.

The Role of the LLM

In the BioMed Reasoning API, the LLM is used only as an explanation layer. It receives the graph-derived data — the targets, pathways, interactions, and evidence — and generates a human-readable summary. It is explicitly instructed never to invent relationships or cite sources not present in the data.

This architecture means the LLM adds value (natural language fluency, contextual explanation) without introducing the risks of hallucination. If the graph does not contain a relationship, the system says so rather than guessing.

Provenance as a First-Class Feature

Every claim in the API response includes provenance: which database provided the data, what identifier was used, what confidence score was assigned, and where to find the original evidence. This is not an afterthought — it is the core architectural principle.

When a researcher or clinician sees that lisinopril inhibits ACE with 95% confidence from ChEMBL, they can independently verify this claim. When they see 34,219 cough reports from OpenFDA FAERS, they can query the FAERS database directly. Every link in the chain is auditable.

When to Use Which Approach

LLM-only approaches are excellent for general medical education, patient communication, and exploratory research where approximate answers are acceptable. Graph reasoning is essential when you need verifiable mechanisms, auditable evidence chains, and structured outputs that downstream systems can consume programmatically.

The BioMed Reasoning API is designed for the second category: developers building clinical tools, researchers needing structured evidence, and safety teams tracing adverse event mechanisms. For these use cases, provenance is not optional — it is the product.